Venture Life Group PLC Notice of Results (1206J)
07 September 2016 - 4:01PM
UK Regulatory
TIDMVLG
RNS Number : 1206J
Venture Life Group PLC
07 September 2016
7 September 2016
Venture Life Group plc
("Venture Life" or the "Group")
Notice of Interim Results
Venture Life (AIM: VLG), the international consumer self-care
group focused on developing, manufacturing and commercialising
products for the ageing population, will announce its Interim
Results for the six months ended 30 June 2016 on 21 September
2016.
A briefing for analysts will take place at the offices of
Walbrook PR, 4 Lombard St., London EC3V 9HD at 9.30am on Wednesday
21 September 2016.
If you would like to register to attend the briefing, or require
further information, please contact Walbrook PR on 020 7933 8780 or
email venturelife@walbrookpr.com.
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive
Officer
James Hunter, Chief Financial
Officer
Panmure Gordon (UK) Limited (Nominated +44 (0) 20 7886
Adviser and Broker) 2500
Freddy Crossley/Peter Steel/Duncan
Monteith (Corporate Finance)
Tom Salvesen (Corporate Broking)
Walbrook PR venturelife@walbrookpr.com
or
+44 (0) 20 7933 8780
+44 (0) 7980 541
Paul McManus 994
+44 (0) 7876 741
Anna Dunphy 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the ageing population. The Group's product range and pipeline
currently includes the UltraDEX oral care products range, food
supplements for lowering cholesterol and maintaining brain
function, dermo-cosmetics for addressing the signs of ageing, and
medical devices for improving minor aches and pains, dry eyes and
itchy skin.
The products, which typically are recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies supplied by the Group's international distribution
partners.
Through its manufacturing company, Biokosmes, the Group also
provides development and manufacturing services to companies in the
medical devices and cosmetic sectors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREQLFBQKFXBBV
(END) Dow Jones Newswires
September 07, 2016 02:01 ET (06:01 GMT)
Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2024 to May 2024
Venture Life (LSE:VLG)
Historical Stock Chart
From May 2023 to May 2024